HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hironori Haga Selected Research

KIR2DL4 Receptors

6/2017Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hironori Haga Research Topics

Disease

56Neoplasms (Cancer)
12/2022 - 08/2005
12Fibrosis (Cirrhosis)
01/2020 - 02/2009
10Hepatitis
08/2017 - 03/2009
8Breast Neoplasms (Breast Cancer)
01/2022 - 02/2015
8Liver Diseases (Liver Disease)
11/2020 - 07/2004
8Hepatocellular Carcinoma (Hepatoma)
11/2020 - 06/2006
7Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2021 - 06/2005
7Lymphoma (Lymphomas)
01/2018 - 12/2005
6Adenocarcinoma of Lung
07/2018 - 06/2014
6Hepatitis C
07/2016 - 03/2008
4B-Cell Lymphoma (Lymphoma, B Cell)
05/2022 - 10/2008
4type 2C Congenital disorder of glycosylation
01/2022 - 03/2013
4Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
03/2021 - 01/2014
4Ascites
05/2020 - 01/2007
4Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2020 - 03/2005
4Lung Neoplasms (Lung Cancer)
12/2019 - 08/2013
4Sclerosing Cholangitis
12/2017 - 08/2006
4Adenocarcinoma
01/2014 - 03/2012
3Carcinoma (Carcinomatosis)
07/2022 - 01/2014
3Neoplasm Metastasis (Metastasis)
01/2020 - 02/2014
3Inflammation (Inflammations)
01/2020 - 03/2008
3Stomach Neoplasms (Stomach Cancer)
12/2019 - 01/2013
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 10/2008
3Immunoglobulin G4-Related Disease
01/2018 - 01/2016
3Mastocytosis
01/2018 - 03/2013
3Hypoxia (Hypoxemia)
01/2015 - 05/2005
3Fever (Fevers)
01/2013 - 04/2008
3Budd-Chiari Syndrome (Budd Chiari Syndrome)
10/2010 - 04/2002
3Autoimmune Hepatitis
08/2006 - 07/2003
2Triple Negative Breast Neoplasms
01/2022 - 07/2021
2Ewing Sarcoma (Sarcoma, Ewing)
10/2021 - 08/2015
2Thrombosis (Thrombus)
01/2021 - 06/2009
2Lymphatic Metastasis
01/2021 - 08/2015
2Liver Neoplasms (Liver Cancer)
12/2020 - 01/2011
2Cholangiocarcinoma
11/2020 - 03/2008
2Jaundice (Icterus)
11/2020 - 04/2011
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 06/2018
2Pancreatitis
01/2018 - 06/2009
2Liver Cirrhosis (Hepatic Cirrhosis)
08/2017 - 07/2016
2Renal Insufficiency (Renal Failure)
08/2017 - 01/2013
2Primary Myelofibrosis (Myelosclerosis)
10/2015 - 01/2013
2Edema (Dropsy)
01/2013 - 01/2004
2Liver Failure
09/2012 - 04/2011
2Infections
01/2012 - 07/2008
2Graft vs Host Disease (Graft-Versus-Host Disease)
05/2010 - 09/2002
2Acute Liver Failure (Fulminant Hepatic Failure)
03/2008 - 03/2005

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
05/2022 - 12/2005
6HLA Antigens (Human Leukocyte Antigens)IBA
01/2020 - 01/2007
5Messenger RNA (mRNA)IBA
05/2022 - 12/2005
5AntibodiesIBA
06/2021 - 11/2012
5RNA (Ribonucleic Acid)IBA
07/2017 - 10/2008
5Antiviral Agents (Antivirals)IBA
10/2014 - 09/2002
4Tyrosine Kinase InhibitorsIBA
12/2022 - 07/2013
4Methotrexate (Mexate)FDA LinkGeneric
08/2021 - 12/2012
4DNA (Deoxyribonucleic Acid)IBA
12/2020 - 03/2008
4Biomarkers (Surrogate Marker)IBA
09/2018 - 02/2015
4SteroidsIBA
01/2018 - 03/2009
4InterferonsIBA
10/2014 - 03/2008
4AntigensIBA
02/2014 - 02/2009
3Paclitaxel (Taxol)FDA LinkGeneric
08/2021 - 01/2015
3Trastuzumab (Herceptin)FDA Link
08/2021 - 01/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 04/2013
3LigandsIBA
01/2020 - 03/2013
3MucinsIBA
07/2018 - 01/2013
3Cytidine DeaminaseIBA
01/2018 - 02/2007
3Anaplastic Lymphoma KinaseIBA
07/2017 - 08/2005
3CytokinesIBA
01/2016 - 03/2008
3human ERBB2 proteinIBA
02/2015 - 01/2013
3Ribavirin (Virazole)FDA LinkGeneric
10/2014 - 03/2008
3Immunosuppressive Agents (Immunosuppressants)IBA
02/2014 - 02/2007
2Insulin-Like PeptidesIBA
05/2022 - 01/2021
2S100 Proteins (S 100 Protein)IBA
02/2022 - 05/2018
2beta CateninIBA
02/2022 - 06/2021
2Leukemia Inhibitory FactorIBA
01/2022 - 01/2020
2Immune Checkpoint InhibitorsIBA
12/2021 - 11/2020
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2021 - 02/2016
2Eosine Yellowish-(YS) (Eosin)IBA
09/2021 - 01/2019
2Hematoxylin (Haematoxylon)IBA
09/2021 - 01/2019
2Carrier Proteins (Binding Protein)IBA
01/2021 - 03/2020
2Serine Proteases (Serine Protease)IBA
01/2020 - 09/2015
2HLA-G Antigens (HLA G)IBA
01/2020 - 08/2015
2Cadherins (E-Cadherin)IBA
01/2019 - 12/2015
2MART-1 AntigenIBA
05/2018 - 11/2016
2Transcription Factors (Transcription Factor)IBA
01/2018 - 03/2011
2Immunoglobulin G (IgG)IBA
01/2016 - 08/2013
2Immunoglobulins (Immunoglobulin)IBA
08/2013 - 01/2011
2Tacrolimus (Prograf)FDA LinkGeneric
09/2012 - 09/2002
2Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2011 - 11/2009
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2010 - 03/2009
2EnzymesIBA
03/2008 - 03/2005
2NF-kappa B (NF-kB)IBA
03/2008 - 08/2005

Therapy/Procedure

49Liver Transplantation
08/2021 - 04/2002
18Therapeutics
03/2022 - 08/2006
9Transplantation
08/2017 - 09/2002
5Drug Therapy (Chemotherapy)
07/2021 - 09/2005
3Neoadjuvant Therapy
01/2022 - 01/2015
3Organ Transplantation
01/2021 - 06/2005
2Splenectomy
04/2017 - 04/2007
2Laparotomy
01/2016 - 01/2014
2Lung Transplantation
03/2015 - 01/2014